XRTX
XRTX
NASDAQ · Pharmaceuticals

Xortx Therapeutics Inc

$0.41
+0.01 (+2.53%)
As of Mar 23, 10:15 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +10,428.4% upside
Low Target $28.32
Average Target $42.64
High Target $47.79
Current Price $0.41
Current
$0.41
Target
$42.64
$28.32 $42.64 avg $47.79
Scenario Analysis
Bear Case
$28.32
6,892.6%
Low target
Base Case
$42.64
+10,428.4%
Avg target
Bull Case
$47.79
+11,700.0%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$1.97
-79.4% from high
52-Week Low
$0.49
+-16.5% from low
Target vs 52W High
$42.64
+2,064.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%